Company Search:
Advanced Search
Sponsored Links
Aphria Inc Company Snapshot
Aphria Inc operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Aphria Inc with three other pharmaceutical manufacturers in North America: Summit Therapeutics PLC of the United States (2019 sales of $56.84 million of which 100% was Drug Discovery), Lifevantage Corp of the United States ($225.96 million ), and Palatin Technologies, Inc. which is also based in the United States ($60.30 million of which 100% was Licenses, Grants and Contracts).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Aphria Inc
  Stock Performance Chart for Aphria Inc
  Stock Data: Recent Stock Performance:
  Current Price (11/15/2019): 5.65
(Figures in Canadian Dollars)
1 Week -16.2%   13 Weeks -9.5%  
4 Weeks -30.8%   52 Weeks -55.5%  
Aphria Inc Key Data:
  Ticker: APHA Country: Canada
  Exchanges: VEN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 237,110,000
(Year Ending Jan 2020).
Employees: 620
  Currency: Canadian Dollars Market Cap: 1,423,876,880
  Fiscal Yr Ends: May Shares Outstanding: 252,013,607
  Share Type: Ordinary Closely Held Shares: 17,351,958
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.